Portfolio company
Qnomx
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Qnomx develops an AI platform for molecular diagnostics laboratories to interpret genomic sequencing data and generate clinical reports for precision oncology.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Imagenomix
The company develops an artificial intelligence platform that predicts cancer mutations from pathology images for healthcare providers and biopharma companies.
Lucid Genomics
This company develops an artificial intelligence platform for long-read genomic data interpretation to assist clinical laboratories and pharmaceutical researchers with diagnostics.
Genomill Health
Genomill Health develops targeted sequencing technology for liquid biopsies to assist clinical laboratories and pharmaceutical companies with precision cancer diagnostics.
GenomOncology
This company develops software platforms to analyse and interpret genomic data for molecular pathology labs, clinical oncologists and research institutions.
Nostos Genomics
The company develops an automated software platform for variant interpretation that helps genetic testing laboratories diagnose patients with rare diseases.
Moonlight AI
This company develops an artificial intelligence diagnostics platform that provides genomic insights from routine blood and marrow smear images for oncology laboratories.
Oncoliq
This company develops liquid biopsy tests using molecular biology and machine learning for early cancer detection in clinical and screening settings.
Nostos
Nostos Genomics develops an artificial intelligence platform to provide genetic variant interpretation and disease diagnosis for medical testing laboratories.
